Old Web
English
Sign In
Acemap
>
authorDetail
>
Douglas Patrick Ross
Douglas Patrick Ross
St Mary's Hospital
Staphylococcus aureus
Telavancin
Antibiotics
Lipoglycopeptide
Medicine
3
Papers
432
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin-Structure Infections Caused by Gram-Positive Organisms
2008
Clinical Infectious Diseases
Martin E. Stryjewski
Donald R. Graham
Samuel E. Wilson
William O'Riordan
David M. Young
Arnold Lentnek
Douglas Patrick Ross
Vance G. Fowler
Alan Hopkins
H. David Friedland
Steven L. Barriere
Michael M. Kitt
G. Ralph Corey
Skin-Structure Infections Study
Show All
Source
Cite
Save
Citations (251)
P845 ATLAS 1: the first Phase 3 study evaluating the new lipoglycopeptide, telavancin, for the treatment of patients with complicated skin and skin structure infections
2007
International Journal of Antimicrobial Agents
G. R. Corey
Martin E. Stryjewski
William O'Riordan
Vance G. Fowler
Douglas Patrick Ross
Alan Hopkins
Michael M. Kitt
Steven L. Barriere
Show All
Source
Cite
Save
Citations (4)
Safety and efficacy of tigecycline in treatment of skin and skin structure infections : Results of a double-blind phase 3 comparison study with vancomycin-aztreonam
2005
Antimicrobial Agents and Chemotherapy
Johannes Breedt
Jüri Teras
Jānis Gardovskis
Maritz Fj
Tiit Vaasna
Douglas Patrick Ross
Martine Gioud-Paquet
Nathalie Dartois
Evelyn J. Ellis-Grosse
Evan Loh
Show All
Source
Cite
Save
Citations (177)
1